- Home
- CNP vs DGX Comparison
CNP vs DGX Comparison
Compare CNP & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNP
- DGX
- Stock Information
- Founded
- CNP 1866
- DGX 1967
- Country
- CNP United States
- DGX United States
- Employees
- CNP N/A
- DGX N/A
- Industry
- CNP Electric Utilities: Central
- DGX Medical Specialities
- Sector
- CNP Utilities
- DGX Health Care
- Exchange
- CNP Nasdaq
- DGX Nasdaq
- Market Cap
- CNP 18.6B
- DGX 17.5B
- IPO Year
- CNP N/A
- DGX 1996
- Fundamental
- Price
- CNP $30.75
- DGX $160.46
- Analyst Decision
- CNP Hold
- DGX Buy
- Analyst Count
- CNP 13
- DGX 13
- Target Price
- CNP $29.83
- DGX $163.38
- AVG Volume (30 Days)
- CNP 5.1M
- DGX 1.0M
- Earning Date
- CNP 10-28-2024
- DGX 10-22-2024
- Dividend Yield
- CNP 2.72%
- DGX 1.87%
- EPS Growth
- CNP 19.15
- DGX 11.56
- EPS
- CNP 1.50
- DGX 7.44
- Revenue
- CNP $8,563,000,000.00
- DGX $9,539,000,000.00
- Revenue This Year
- CNP $4.45
- DGX $7.33
- Revenue Next Year
- CNP $3.66
- DGX $8.69
- P/E Ratio
- CNP $20.56
- DGX $21.57
- Revenue Growth
- CNP N/A
- DGX 2.60
- 52 Week Low
- CNP $25.41
- DGX $123.04
- 52 Week High
- CNP $31.57
- DGX $162.59
- Technical
- Relative Strength Index (RSI)
- CNP 57.05
- DGX 60.76
- Support Level
- CNP $29.96
- DGX $156.10
- Resistance Level
- CNP $31.07
- DGX $162.59
- Average True Range (ATR)
- CNP 0.75
- DGX 2.91
- MACD
- CNP 0.06
- DGX 0.37
- Stochastic Oscillator
- CNP 69.20
- DGX 79.72
About CNP CenterPoint Energy Inc (Holding Co)
CenterPoint Energy owns a portfolio of businesses. Its regulated electric utilities provide transmission and distribution services to more than 2.5 million customers in the Houston area, southern Indiana, and west central Ohio. The company has natural gas distribution systems serving approximately 4 million customers.
About DGX Quest Diagnostics Incorporated
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.